Market Overview:
The global clinical trails management systems market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for cloud-based clinical trails management systems and rising adoption of clinical trials by pharmaceutical and biotechnology companies, healthcare providers, and CROs. However, the high cost associated with deployment and maintenance of on-premise CTMS solutions is expected to restrain the growth of the market during the forecast period. On basis of type, cloud-based CTMS held a dominant share in 2017 and is projected to grow at a higher CAGR during forecast period owing to its advantages such as scalability, flexibility, lower total cost ownership (TCO), and easy accessibility from anywhere across the globe.
Product Definition:
A clinical trails management system (CTMS) is a software application that helps manage the complexities of running a clinical trial. A CTMS can automate many tasks, such as tracking study participants, managing budgets and invoices, and generating reports. The importance of a CTMS depends on the size and complexity of the trial. For small trials, a simple spreadsheet may suffice. But for large trials with numerous sites and stakeholders, a CTMS can be essential for ensuring that all aspects of the study are properly coordinated.
Cloud-based:
Cloud-based is a term used to define data that is stored and retrieved from remote servers using software applications. The cloud can be described as a shared pool of internet connections, storage devices, and computer systems that are connected via the internet. Cloud computing involves sharing resources among multiple users so that they may utilize it simultaneously without having to establish an infrastructure on their own.
On-premise:
On-premise is a computer software system installed at the organization's headquarters for processing and storing data. It is an internal database that can only be accessed by authorized personnel. The information stored in on-premise systems cannot be seen or edited by users outside the organization, hence it provides more privacy as compared to cloud computing systems.
Application Insights:
The pharmaceutical and biotechnology companies segment dominated the global clinical trails management systems market in 2017. This is attributed to the growing number of product launches and frequent approvals for new drugs. For instance, in 2018, Pfizer Inc., a U.S.-based multinational pharmaceutical company, announced its plan to invest around USD 1 billion annually on R&D by 2020 through various initiatives such as acquisitions & partnerships etc.
Moreover, an increasing number of pipeline products with potential for commercialization is expected to drive industry growth over the forecast period. For instance, in January 2019 Farrlea Pharmaceuticals Ltd., a UK-based biopharmaceutical company has announced that it has entered into a partnership with Acelity Therapeutics Pty Ltd.
Regional Analysis:
North America accounted for the largest share of global CTMS market in 2017. The region is expected to maintain its dominance over the forecast period owing to factors such as increasing R&D activities, high healthcare expenditure and technological advancements. In addition, growing number of clinical trials conducted in this region is also anticipated to drive regional growth during the forecast period.
Asia Pacific is estimated to be one of the fastest-growing regions during the same period owing to increasing outsourcing activities by Asian countries such as China and India pertaining towards clinical trials management services. Moreover, government support for promoting medical tourism in Asia Pacific countries will boost regional growth further due rising demand from patients & physicians across various industries requiring efficient research practices & tools for effective data management needs (Pharmaceuticals & Biotechnology; Medical Devices).
Growth Factors:
- Increasing demand for novel therapeutics and personalized medicines
- Rising prevalence of chronic diseases and growing geriatric population
- Growing number of clinical trials globally
- Technological advancements in CTMS software
- Increasing outsourcing of clinical trials by pharmaceutical and biotechnology companies
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Trails Management Systems Market Research Report
By Type
Cloud-based, On-premise
By Application
Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Healthcare Providers
By Companies
Medidata Solutions, PAREXEL International Corporation,, BioClinica,, Merge Healthcareorporated,, MedNet Solutions, Oracle Corporation,, Bio-Optronics, Integrated Clinical Solutions
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Trails Management Systems Market Report Segments:
The global Clinical Trails Management Systems market is segmented on the basis of:
Types
Cloud-based, On-premise
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Healthcare Providers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medidata Solutions
- PAREXEL International Corporation,
- BioClinica,
- Merge Healthcareorporated,
- MedNet Solutions
- Oracle Corporation,
- Bio-Optronics
- Integrated Clinical Solutions
Highlights of The Clinical Trails Management Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cloud-based
- On-premise
- By Application:
- Pharmaceutical and Biotechnology Companies
- Clinical Research Organizations
- Healthcare Providers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Trails Management Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clinical trails management systems (CTMS) are a type of electronic health record (EHR) system that helps healthcare providers track the safety and effectiveness of new treatments and therapies. CTMS can help identify problems early, so they can be corrected before patients experience any adverse effects.
Some of the major players in the clinical trails management systems market are Medidata Solutions, PAREXEL International Corporation,, BioClinica,, Merge Healthcareorporated,, MedNet Solutions, Oracle Corporation,, Bio-Optronics, Integrated Clinical Solutions.
The clinical trails management systems market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Trails Management Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Trails Management Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Trails Management Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Trails Management Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Trails Management Systems Market Size & Forecast, 2020-2028
4.5.1 Clinical Trails Management Systems Market Size and Y-o-Y Growth
4.5.2 Clinical Trails Management Systems Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cloud-based
5.2.2 On-premise
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical and Biotechnology Companies
6.2.2 Clinical Research Organizations
6.2.3 Healthcare Providers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clinical Trails Management Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Trails Management Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cloud-based
9.6.2 On-premise
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical and Biotechnology Companies
9.10.2 Clinical Research Organizations
9.10.3 Healthcare Providers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cloud-based
10.6.2 On-premise
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical and Biotechnology Companies
10.10.2 Clinical Research Organizations
10.10.3 Healthcare Providers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cloud-based
11.6.2 On-premise
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical and Biotechnology Companies
11.10.2 Clinical Research Organizations
11.10.3 Healthcare Providers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cloud-based
12.6.2 On-premise
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical and Biotechnology Companies
12.10.2 Clinical Research Organizations
12.10.3 Healthcare Providers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cloud-based
13.6.2 On-premise
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical and Biotechnology Companies
13.10.2 Clinical Research Organizations
13.10.3 Healthcare Providers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clinical Trails Management Systems Market: Competitive Dashboard
14.2 Global Clinical Trails Management Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medidata Solutions
14.3.2 PAREXEL International Corporation,
14.3.3 BioClinica,
14.3.4 Merge Healthcareorporated,
14.3.5 MedNet Solutions
14.3.6 Oracle Corporation,
14.3.7 Bio-Optronics
14.3.8 Integrated Clinical Solutions
